1. Neijt, J.P., ten Bokkel Huinink, W.W., van den Burg, M.E.L. et
al (1991) Long term results of chemotherapy in advanced (FIGO Stages III or IV) ovarian cancer. Int. Gynecol Cancer Soc., (abstract), 36.
2. Neijt, J.P., ten Bokkel Huinink, W.W., van den Burg, M.E.L. et al (1987) Randomized trial comparing two combination chemotherapy regimens (CHAP-5 vs CP) in advanced ovarian carcinoma, J. Clin. Oncol. 51157–68.
3. Vogl, S.E., Pagano, M., Kaplan, B.H. et al. (1983) Cisplatin based combination chemotherapy for advanced ovarian cancer: high overall response rate with curative potential only in women with small tumour burdens. Cancer
512024–30.
4. Omura, G.A., Blessing, J.A., Ehrlich, C.E. et al. (1986) A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma: a Gynecologic Oncology Group study.Cancer
571725–30.
5. Dembo, A.J. (1984) Abdominopelvic radiotherapy in ovarian cancer: a 10-year experience. Cancer
55,2285–90.